体外膜肺氧合的适应症和并发症。

ECMO indications and complications.

作者信息

Donn S M

机构信息

Section of Newborn Services, University of Michigan Medical Center, Ann Arbor.

出版信息

Hosp Pract (Off Ed). 1990 Jun 15;25(6):143-6, 149-50, 153-7. doi: 10.1080/21548331.1990.11703962.

DOI:10.1080/21548331.1990.11703962

PMID:2112142

Abstract

Widely adopted while prospective validation was still under way, extracorporeal membrane oxygenation is now a clinically established treatment for reversing neonatal respiratory failure. The technique's accomplishments are impressive-83% survival in conditions otherwise associated with 80% mortality-but its problems include significant handicap in 20% of treated survivors.

摘要

体外膜肺氧合技术在仍处于前瞻性验证阶段时就被广泛采用，如今已成为临床上用于逆转新生儿呼吸衰竭的既定治疗方法。该技术取得的成果令人瞩目——在原本死亡率高达80%的情况下，存活率达到了83%——但其问题在于，20%接受治疗的幸存者存在严重残疾。